Skip to main content

Travere Therapeutics, Inc 10-Q for FY2025 Q2

Travere Therapeutics, Inc. (TVTX)

10-Q 2025-08-06 For: 2025-06-30
View Original
Added on April 07, 2026

About this 10-Q

Travere Therapeutics, Inc filed this 10-Q on August 6, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$114.45M
up 111.5% from $54.12M a year earlier
Net loss
$12.76M
compared with a net loss of $70.41M a year earlier
Diluted EPS
-$0.14
compared with -$0.91 a year earlier